Skip to main content
. Author manuscript; available in PMC: 2016 Jul 15.
Published in final edited form as: Behav Brain Res. 2015 Apr 9;288:54–62. doi: 10.1016/j.bbr.2015.04.002

Fig. 4.

Fig. 4

Intra-VTA mecamylamine effects on the FST immobility time and total locomotor activity. A. Mecamylamine infusion into the VTA leads to decreased immobility time in the FST (p < 0.05, main effect of drug; p < 0.05, Tukey post-hoc for 30 μg/side mecamylamine versus saline). B. Intra-VTA infusion of 30 μg/side mecamylamine did not alter locomotor activity as measured by locomotor beam breaks (p > 0.05, two-way repeated measures ANOVA). C. Representative VTA cannula placements for the mecamylamine infusion experiment.